Hasil Pencarian (1)
small molecule | CAS: 516-54-1
As of March 2019, brexanolone - developed and made available commercially by Sage Therapeutics Inc. as the brand name product Zulresso - is the first drug to have ever been approved by the US FDA specifically for the treatment of postpartum depression (PPD) i…
Kategori:
AnestheticsAnticonvulsantsAntidepressive Agents
+28
Target Protein:
Gamma-aminobutyric acid receptor subunit deltaGamma-aminobutyric acid receptor subunit gamma-3GABA(A) Receptor
+3
Waktu ParuhThe terminal half-l…
Vol. DistribusiThe volume of distr…
KlirensThe total plasma cl…
Genetik
-